IMS
BMRN icon

Index Management Solutions’s BioMarin Pharmaceuticals BMRN Stock Holding History

Index Management Solutions’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$23K Sell
217
-128
-37% -$17.1K 0.02% 380
2015
Q2 		$47K Buy
345
+105
+44% +$13K 0.04% 255
2015
Q1 		$30K Buy
+240
New +$25.4K 0.02% 248

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Index Management Solutions's BMRN Position: Q3 2015 in Review

Index Management Solutions reduced its BioMarin Pharmaceuticals (BMRN) stake by 37% in Q3 2015, selling an estimated $17.1K and leaving 217 shares worth $23K. The position accounts for 0.02% of the portfolio, ranked #380.

Index Management Solutions first reported a position in BMRN in Q1 2015 and has held it in 3 quarters since. The position peaked at $47K in Q2 2015. 393 funds tracked by Wall St. Rank hold BMRN as of Q3 2015.

  • Index Management Solutions held 217 shares of BioMarin Pharmaceuticals worth $23K as of Q3 2015.
  • Index Management Solutions sold 128 BioMarin Pharmaceuticals shares in Q3 2015, an estimated $17.1K.
  • BioMarin Pharmaceuticals made up 0.02% of Index Management Solutions's portfolio in Q3 2015, its #380 holding.
  • Index Management Solutions first reported a position in BioMarin Pharmaceuticals in Q1 2015 and has held it in 3 quarters since.
  • Index Management Solutions's BioMarin Pharmaceuticals position peaked at $47K in Q2 2015.
  • 393 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.